All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Lobbying for SPARK THERAPEUTICS, INC. · Biopharmaceutical/gene therapy company
Filing
2nd Quarter - Termination
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 16, 2025
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
Pennsylvania
Representation ended
May 31, 2025
The registrant reported terminating its work for this client.
Lobbying activity
1
Issues related to the development of gene therapies for rare diseases